Angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use and outcomes in patients with colorectal cancer

被引：0
|
作者：
Tuazon, Sherilyn Alvaran
King, Gantry Teng
Cruz, Joanna Sta.
Chae, Young K.
Koc, Jean B. Ong Klan
Hegarty, Sarah
Leighton, John Charles
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Albert Einstein Heathcare Network, Philadelphia, PA USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e14516
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14516
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Angiotensin converting enzyme inhibitor and angiotensin receptor blocker use and outcomes in patients with colorectal cancer.
    Tuazon, Sherilyn Alvaran
    King, Gentry Teng
    Cruz, Joanna Paula Pingol Sta
    Koc, Jean B. Ong Kian
    Chae, Young Kwang
    Leighton, John Charles
    Daskalakis, Constantine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [2] Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis
    Shen, Jenny I.
    Saxena, Anjali B.
    Montez-Rath, Maria E.
    Chang, Tara I.
    Winkelmayer, Wolfgang C.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (05) : 862 - 869
  • [3] Associations of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use with Colorectal Cancer Risk in the Women's Health Initiative
    Brasky, Theodore M.
    Flores, Katrina F.
    Larson, Joseph C.
    Newton, Alison M.
    Shadyab, Aladdin H.
    Watanabe, Jonathan H.
    Lane, Dorothy S.
    Thomson, Cynthia A.
    LaCroix, Andrea Z.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (05) : 1029 - 1032
  • [4] Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease
    Molnar, Miklos Z.
    Kalantar-Zadeh, Kamyar
    Lott, Evan H.
    Lu, Jun Ling
    Malakauskas, Sandra M.
    Ma, Jennie Z.
    Quarles, Darryl L.
    Kovesdy, Csaba P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (07) : 650 - 658
  • [5] Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury
    Brar, Sandeep
    Ye, Feng
    James, Matthew T.
    Hemmelgarn, Brenda
    Klarenbach, Scott
    Pannu, Neesh
    [J]. JAMA INTERNAL MEDICINE, 2018, 178 (12) : 1681 - 1690
  • [6] Paradoxical pressor response with angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Sabitha, P.
    Adhikari, Prabha M.
    [J]. AUSTRALASIAN MEDICAL JOURNAL, 2011, 4 (07): : 364 - +
  • [7] Effects of combination therapy of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker
    Idrizi, A
    Gjata, M
    Barbullushi, M
    Koroshi, A
    Tase, M
    Sadiku, E
    Hoti, K
    [J]. JOURNAL OF HYPERTENSION, 2005, 23 : S398 - S398
  • [8] Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria
    Chu, Chi D.
    Powe, Neil R.
    McCulloch, Charles E.
    Banerjee, Tanushree
    Crews, Deidra C.
    Saran, Rajiv
    Bragg-Gresham, Jennifer
    Morgenstern, Hal
    Pavkov, Meda E.
    Saydah, Sharon H.
    Tuot, Delphine S.
    [J]. HYPERTENSION, 2021, 77 (01) : 94 - 102
  • [9] Optimal dose of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker for renoprotection
    Hou, Fan Fan
    Zhou, Qiu Gen
    [J]. NEPHROLOGY, 2010, 15 : 57 - 60
  • [10] Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use and Renal Outcomes: Prevalent User Designs May Overestimate Benefit
    Tomlinson, Laurie
    Smeeth, Liam
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (10) : 1706 - 1706
12345